Literature DB >> 4025005

Paradoxical esterification of plasma cholesterol in fish eye disease.

L A Carlson, L Holmquist.   

Abstract

The activity of lecithin: cholesterol acyl transferase (LCAT), the enzyme which catalyses the esterification of human plasma cholesterol, has been measured by two independent methods in plasma from the two known living Swedish patients with fish eye disease. The enzyme activity was in both cases about 15% of that of normal plasma. Paradoxically, however, the percentage of plasma cholesterol which was esterified was almost normal in both patients. In addition, a normal spectrum of the fatty acids of the cholesteryl esters was present indicating a normal cholesterol esterification pathway in vivo. Incubation experiments in vitro of plasma from the two patients also yielded normal cholesterol esterification rates when measured by two different methods. These paradoxical results for cholesterol esterification are discussed on the basis of the present biochemical knowledge of fish eye disease and LCAT deficiency.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4025005     DOI: 10.1111/j.0954-6820.1985.tb03252.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  8 in total

1.  A molecular defect causing fish eye disease: an amino acid exchange in lecithin-cholesterol acyltransferase (LCAT) leads to the selective loss of alpha-LCAT activity.

Authors:  H Funke; A von Eckardstein; P H Pritchard; J J Albers; J J Kastelein; C Droste; G Assmann
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

2.  Fish eye syndrome: a molecular defect in the lecithin-cholesterol acyltransferase (LCAT) gene associated with normal alpha-LCAT-specific activity. Implications for classification and prognosis.

Authors:  H G Klein; S Santamarina-Fojo; N Duverger; M Clerc; M F Dumon; J J Albers; S Marcovina; H B Brewer
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

3.  Two different allelic mutations in the lecithin-cholesterol acyltransferase gene associated with the fish eye syndrome. Lecithin-cholesterol acyltransferase (Thr123----Ile) and lecithin-cholesterol acyltransferase (Thr347----Met).

Authors:  H G Klein; P Lohse; P H Pritchard; D Bojanovski; H Schmidt; H B Brewer
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

Review 4.  Familial LCAT deficiency and fish-eye disease.

Authors:  N McIntyre
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

5.  Decreased lecithin:cholesterol acyltransferase activity in the plasma of hypercholesterolemic pigs.

Authors:  A G Lacko; S M Lee; I Mirshahi; J Hasler-Rapacz; B J Kudchodkar; J Rapacz
Journal:  Lipids       Date:  1992-04       Impact factor: 1.880

Review 6.  Analysis of familial hypoalphalipoproteinemia syndromes.

Authors:  J Frohlich; P H Pritchard
Journal:  Mol Cell Biochem       Date:  1992-08-18       Impact factor: 3.396

Review 7.  Lecithin: cholesterol acyltransferase--from biochemistry to role in cardiovascular disease.

Authors:  Xavier Rousset; Boris Vaisman; Marcelo Amar; Amar A Sethi; Alan T Remaley
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2009-04       Impact factor: 3.243

Review 8.  A systematic review of the natural history and biomarkers of primary lecithin:cholesterol acyltransferase deficiency.

Authors:  Cecilia Vitali; Archna Bajaj; Christina Nguyen; Jill Schnall; Jinbo Chen; Kostas Stylianou; Daniel J Rader; Marina Cuchel
Journal:  J Lipid Res       Date:  2022-01-20       Impact factor: 5.922

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.